相关实验视频

Updated: Jun 10, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

在EGFR突变肺癌的基础上存在着多种原发性瘤的发育马赛克

Risa Burr¹, Ignaty Leshchiner^2,3, Christina L Costantino^1,4

¹Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.

|October 15, 2024

概括

非吸烟者的多个EGFR突变肺瘤可能来自发育的马赛克,一个独特的遗传倾向机制. 这一发现影响了对非小细胞肺癌的起源和治疗的理解.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

吸烟者的多重初级肺瘤通常与致癌物暴露 (现场癌症) 有关.
在没有已知暴露的非吸烟者中,多种EGFR突变肺瘤的起源尚不清楚.

研究的目的:

为了研究多种不同的EGFR突变非小细胞肺癌 (NSCLC) 瘤的潜在机制,在没有已知的环境暴露的患者中呈现.
确定有助于发展多种原发性EGFR突变肺瘤的遗传倾向.

主要方法:

整体外体序列测序 (WES) 和高变异性多氨酸 (多氨酸) (多氨酸G)) 重复基因型鉴定用于谱系追踪.
对十名患有早期,可切除NSCLC的患者的多种瘤进行了基因分析.
实验室建模用于评估已识别的生殖线EGFR变异的功能影响.

主要成果:

四名患者表现出发育性马赛克的证据,这表明他们的多种瘤的共同非胚胎细胞起源.
两名患者的生殖线EGFR变异在体外增强了信号活动.
发育的马赛克和生殖线EGFR变异被确定为具有多个EGFR突变瘤的特异性机制.

结论:

发育性马赛克代表了对多种原发性EGFR突变肺癌的遗传倾向的新机制.
生殖系EGFR变异也会导致多种EGFR突变瘤的发展.
这些发现对了解病因学和指导EGFR突变NSCLC的临床治疗具有重要意义.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...